| VR-Moodboost; an Innovative Virtual Reality Treatment for Adolescents With Depression (NCT05486676) | Claudi Bockting | 2022-07-25 |
| Mobile Observation Of Depression (NCT05815459) | Emteq Ltd | 2022-07-15 |
| Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser (NCT05435820) | Peruvian Clinical Research | 2022-07-01 |
| aiTBS for Relieving NSSI in Depressive Patients (NCT05384405) | Central South University | 2022-07-01 |
| Glutamate Emotion Memory Study (NCT05809609) | University of Oxford | 2022-07-01 |
| Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers (NCT05603819) | Alcediag | 2022-06-29 |
| The Effects of Videogames on Depression Symptoms and Brain Dynamics (NCT05426265) | Aalto University | 2022-06-28 |
| Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression (NCT05422417) | Taipei Veterans General Hospital, Taiwan | 2022-06-07 |
| TBS Treatment for Treatment-Resistant Depression (NCT05388539) | University of Sao Paulo | 2022-06-06 |
| Pilot Decentralized Trial (NCT05419869) | Alto Neuroscience | 2022-06-01 |
| Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder (NCT05950061) | KRL Hospital, Islamabad | 2022-06-01 |
| The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder (NCT06203015) | Lithuanian University of Health Sciences | 2022-06-01 |
| Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning (NCT05400785) | Hucircadian | 2022-05-27 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder (NCT05376150) | Xenon Pharmaceuticals Inc. | 2022-05-19 |
| Effects of a Single Dose of Amisulpride on Functional Brain Changes (NCT05347199) | Simone Grimm | 2022-05-17 |
| Alleviating Stress by Mobile Application' for Depression (NCT05312203) | Korea University Guro Hospital | 2022-05-15 |
| Empower: tDCS for Major Depressive Disorder at Home (NCT05202119) | Flow Neuroscience AB | 2022-05-12 |
| Therapist-Guided Smartphone-Delivered CBT for MDD (NCT05386329) | Massachusetts General Hospital | 2022-05-11 |
| Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets (NCT05046184) | University of Texas Southwestern Medical Center | 2022-05-05 |
| Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive Disorder (NCT05353543) | The Third Affiliated hospital of Zhejiang Chinese Medical University | 2022-05-01 |
| Intradermal Needle Therapy for Major Depressive Disorder (NCT05352113) | The Third Affiliated hospital of Zhejiang Chinese Medical University | 2022-05-01 |
| Neurocognitive Effects of FMT in MDD Patients With and Without IBS (NCT05174273) | Valerie Taylor | 2022-04-06 |
| Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation (NCT04502758) | Mayo Clinic | 2022-04-04 |
| Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms (NCT05317481) | Yale University | 2022-04-01 |
| Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study (NCT05950711) | Ohio State University | 2022-03-30 |
| Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression (NCT05045378) | Taipei Veterans General Hospital, Taiwan | 2022-03-15 |
| Medication Reviews in Severe Mental Illness (NCT05243160) | Psychiatric Research Unit, Region Zealand, Denmark | 2022-03-11 |
| rTMS for Suicidality in Opioid Use Disorder (NCT04785456) | Centre for Addiction and Mental Health | 2022-03-01 |
| The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN) (NCT06131268) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2022-03-01 |
| Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer (NCT04973930) | New York State Psychiatric Institute | 2022-03-01 |
| Effects of Ghrelin Administration on Dopamine and Effort (NCT05318924) | University Hospital Tuebingen | 2022-02-21 |
| Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) (NCT05203341) | Neurocrine Biosciences | 2022-02-21 |
| Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder (NCT05181527) | All India Institute of Medical Sciences, Bhubaneswar | 2022-02-10 |
| A Trial of Enhanced Versus Standard Measurement-Based Care Implementation for Depression (NCT05577494) | Shanghai Mental Health Center | 2022-02-10 |
| Cognitive Dysfunction in the Addictions Study - Project 4 (P4) (NCT06299787) | Centre for Addiction and Mental Health | 2022-02-07 |
| Aβ Dynamics in LLMD (NCT05004987) | NYU Langone Health | 2022-02-04 |
| ALTO-300 in Depression (ALTO-300-004) (NCT05157945) | Alto Neuroscience | 2022-02-03 |
| Intensive tDCS for MDD: Feasibility Study (NCT05194267) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-02-02 |
| Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD) (NCT05205915) | Neuroelectrics Corporation | 2022-02-02 |
| Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial (NCT05142683) | Centre for Addiction and Mental Health | 2022-02-01 |
| Efficacy and Safety of Light Therapy in the Treatment of Non-seasonal Depressive Disorder in Chinese Population (NCT05499117) | Shanghai Mental Health Center | 2022-02-01 |
| Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities (NCT05104918) | Scotmann Pharmaceuticals | 2022-02-01 |
| NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder (NCT05136755) | China Medical University Hospital | 2022-01-25 |
| Pulse Width 0.15ms vs 0.30ms in Electroconvulsive Therapy (NCT05465915) | Charles University, Czech Republic | 2022-01-18 |
| Pilot Study of a Brief Behavioural Activation Intervention for Depressed Patients in Primary Care (NCT05273983) | University of Manitoba | 2022-01-14 |
| KAP for Depression in Abstinent Opioid Users (NCT05193318) | Medical University of South Carolina | 2022-01-13 |
| Scaling Mental Healthcare in COVID-19 With Voice Biomarkers (NCT04510519) | Kintsugi Mindful Wellness, Inc. | 2022-01-12 |
| The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls (NCT06114342) | Xiaomei Shao | 2022-01-10 |
| Vagal Nerve Stimulation for Treatment Resistant Major Depression (NCT04990687) | University of Alabama at Birmingham | 2022-01-01 |
| Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder (NCT05605002) | Xiaomei Shao | 2022-01-01 |
| RTMS Feasibility Study on Adolescent Depression Stimulation (NCT06126198) | Uppsala University | 2022-01-01 |
| A Novel Cognitive Remediation Intervention Targeting Poor Decision-making and Depression in Veterans at High Risk for Suicide: A Safe, Telehealth Approach During the COVID-19 Pandemic (NCT04952532) | VA Office of Research and Development | 2022-01-01 |
| Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression (NCT05630963) | Mclean Hospital | 2021-12-29 |
| A Study of Xiongdan Wan Treating Depression (NCT05136365) | Shanghai Mental Health Center | 2021-12-28 |
| The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling (NCT05212389) | Rigshospitalet, Denmark | 2021-12-22 |
| Triage Survey for Psychiatry Research Eligibility (NCT05800925) | Adams Clinical | 2021-12-21 |
| ALTO-100 in MDD and/or PTSD (NCT05117632) | Alto Neuroscience | 2021-12-20 |
| ALTO-300 in Depression (NCT05118750) | Alto Neuroscience | 2021-12-13 |
| RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma (NCT05217758) | Amsterdam UMC, location VUmc | 2021-12-09 |
| Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD (NCT05165394) | Neurocrine Biosciences | 2021-11-30 |
| Inter-Brain Synchrony in Psychotherapy for Depression (NCT06196346) | University of Haifa | 2021-11-23 |
| ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION (NCT04724447) | Laureate Institute for Brain Research, Inc. | 2021-11-23 |
| RESET-psychotherapy: the Effectiveness of Trauma-focused Therapy in Patients With Depression and Childhood Trauma (NCT05149352) | Amsterdam UMC, location VUmc | 2021-11-10 |
| Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder (NCT05271084) | Hawler Medical University | 2021-11-10 |
| Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot Trial (NCT04957368) | Unity Health Toronto | 2021-11-03 |
| Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity (NCT02369393) | Universitat Jaume I | 2021-11-02 |
| Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia (NCT05084924) | University of North Carolina, Chapel Hill | 2021-11-02 |
| Neurobiology of Treatment Responses in MDD (NCT03068247) | University of Utah | 2021-11-01 |
| Chinese Longitudinal and Systematic Study of Bioplar Disorder (NCT05480150) | First Affiliated Hospital of Zhejiang University | 2021-11-01 |
| Effects of Electroacupuncture With Different Frequencies for Major Depressive Disorder (NCT05144880) | Zhejiang Chinese Medical University | 2021-11-01 |
| Acupuncture for Patients With Major Depressive Disorder (NCT05106868) | Chengdu University of Traditional Chinese Medicine | 2021-11-01 |
| Virtual Reality Reward Training and Transcranial Magnetic Stimulation for Depression (NCT06178731) | Sunnybrook Health Sciences Centre | 2021-10-29 |
| Investigating Biological Markers, Targets, and Intervention for Mood Disorders (NCT04632498) | Vanderbilt University Medical Center | 2021-10-26 |
| XEN1101 for Major Depressive Disorder (NCT04827901) | James Murrough | 2021-10-19 |
| Improving Health Care in Major Depressive Disorder (NCT05816018) | Ospedale San Raffaele | 2021-10-12 |
| Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS in Depression and Anxiety (NCT05028738) | University of British Columbia | 2021-10-11 |
| HypErthermia as an Additional Treatment for the Biology and Experience of Depression (NCT05041361) | University of California, San Francisco | 2021-10-11 |
| An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder (NCT05061719) | Intra-Cellular Therapies, Inc. | 2021-10-08 |
| Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients (NCT05239780) | Icahn School of Medicine at Mount Sinai | 2021-10-06 |
| Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder (NCT04466345) | University Health Network, Toronto | 2021-10-06 |
| Brain Insulin Resistance in Mood Disorders (NCT03915613) | University Health Network, Toronto | 2021-10-06 |
| Confirm the Effectiveness of Predictix Genetics Antidepressant -Guided Treatment in Adults With MDD (NCT05137197) | Taliaz Ltd. | 2021-10-04 |
| Positive Processes and Transition to Health (NCT04678232) | Case Western Reserve University | 2021-10-01 |
| TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic (NCT04780152) | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 2021-10-01 |
| The Efficacy of Probiotic Compared With Placebo Commitment Therapy for Treatment of Major Depressive Disorder (NCT05315401) | Min-Tze LIONG | 2021-10-01 |
| Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression (NCT05194098) | San Francisco Veterans Affairs Medical Center | 2021-10-01 |
| Transcranial Magnetic Stimulation Theta Burst (TMS), Depression and Smoking. (NCT05694754) | Dr. Julian Reyes López | 2021-10-01 |
| Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder (NCT05061706) | Intra-Cellular Therapies, Inc. | 2021-09-30 |
| Predictors of Cognitive Outcomes in Geriatric Depression (NCT05273996) | David Steffens | 2021-09-28 |
| The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments (NCT05135897) | Haukeland University Hospital | 2021-09-27 |
| Stellate Ganglion Block for Major Depressive Disorder. (NCT04727229) | Unity Health Toronto | 2021-09-23 |
| Biomarker-guided rTMS for Treatment Resistant Depression (NCT04041479) | Weill Medical College of Cornell University | 2021-09-17 |
| Efficacy and Cost-effectiveness of Internet-delivered CBT for Adolescents With Depression (NCT04977856) | Region Stockholm | 2021-09-10 |
| Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT) (NCT05537558) | University Hospital Muenster | 2021-09-09 |
| MRI Markers of Feedback Timing During Learning in Individuals with TBI with and Without Clinical Depression (NCT05009511) | Kessler Foundation | 2021-09-01 |
| Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents (NCT05571878) | Centre for Addiction and Mental Health | 2021-09-01 |
| Targeting IL-17A for Treatment-Resistant Depression (NCT04979910) | Icahn School of Medicine at Mount Sinai | 2021-08-27 |
| Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder (NCT04975100) | All India Institute of Medical Sciences, Bhubaneswar | 2021-08-26 |
| Reward Emotion Learning and Ketamine Study (NCT04850911) | University of Oxford | 2021-08-25 |
| SSIPP vs. PST vs. WLC (NCT04887350) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-08-09 |